Holen Sie sich die Stockscreener-App
4.59
1.08%
-0.05
Handel nachbörslich:
3.43
-1.16
-25.27%
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
What's Driving the Buzz Around MiMedx Group, Inc. (MDXG) in Healthcare Stocks? - Kalkine Media
What Does the AXIOFILL Court Ruling Mean for MiMedx (NASDAQ:MDXG)? - Kalkine Media
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG - Moomoo
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter - Investing News Network
Court vacates FDA rulings on MiMedx’s AXIOFILL classification - Investing.com
U.S. District Court Orders FDA to Reclassify MiMedx Wound Powder as Device - Lawxy AI
FDA Must Revisit MiMedx Wound Care Powder Classification - Law360
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 53.85% Potential Upside in Biotechnology - DirectorsTalk Interviews
MiMedx Group stock steadies as investors look to upcoming catalysts - AD HOC NEWS
MiMedx Group (MDXG) Holds Steady at $4.76 as Traders Eye $5.00 ResistanceMerger Arbitrage - careplusvn.com
Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 By Investing.com - Investing.com India
Two New York conferences will include MIMEDX executives on Sept. 9 and 10 - Stock Titan
MIMEDX GROUP, INC. SEC Filing (Sep 8, 2026) - Stock Titan
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
MDXG Should I Buy - Intellectia AI
MiMedx (MDXG) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period; Session Move - dars.gov.et
MiMedx Group (NASDAQ: MDXG) readies shares for business combination - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn
MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - vinanet.vn
Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx Group (MDXG) Climbs 3.83% to $4.34, Approaching Key Resistance LevelPrice Action Signals - dars.gov.et
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - TradingKey
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation ContinuesUnusual Put Volume - dars.gov.et
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx to acquire Sanara MedTech for $350M - MassDevice
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - tradingview.com
MiMedx Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E - GuruFocus
MiMedx: Q2 Earnings Snapshot - Marietta Daily Journal
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ) - Seeking Alpha
Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside - GuruFocus
MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MiMedx Group Inc (MDXG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MiMedx Group Inc (MDXG) Earnings Date & Reports & Earnings News - TradingKey
MiMedx Group Inc (MDXG) Institutional Confidence - TradingKey
MiMedx Group Inc (MDXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MiMedx Group Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MDXG|MiMedx Group Inc|Price:4.340|Chg%:+0.080 - TradingKey
Paradigm Capital Management Inc. NY Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group, Inc Revenue Breakdown – BOATS:MDXG - TradingView
MDXG|MiMedx Group Inc|Price:4.200|Chg%:+0.070 - TradingKey
MiMedx Group (MDXG) Holds Near Support Amid Modest PullbackEntry Point Alerts - dars.gov.et
MiMedx Group (MDXG) Expected to Announce Earnings on Wednesday - MarketBeat
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):